| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $438.95 | $3,511,603.66 | -46.7% | +11.2% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Boyle Dana | Chief Accounting Officer | Sell | 1,238 | $23.41 | $28,981.58 | -0.7% | +54.0% | - | |
| Oct 13, 2025 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 400 | $90.09 | $36,036.00 | -0.5% | -4.8% | - | |
| Oct 13, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael | President And COO | Sell | 22,500 | $440.35 | $9,907,962.75 | -100% | +9.6% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Krepp Sarah | Chief Human Resource Officer | Sell | 1,691 | $23.41 | $39,586.31 | -1.2% | +54.0% | - | |
| Oct 13, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $54.38 | $143,400.06 | -1.6% | -40.9% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 3,670 | $23.41 | $85,914.70 | -2.0% | +54.0% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Jeffs Roger67 | Chief Executive Officer | Sell | 20,261 | $23.41 | $474,310.01 | -1.9% | +54.0% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Schundler Russell59 | General Counsel | Sell | 7,839 | $23.41 | $183,510.99 | -1.3% | +54.0% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 5,327 | $23.41 | $124,705.07 | -2.1% | +54.0% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Kaseta Michael58 | CFO And COO | Sell | 11,630 | $23.41 | $272,258.30 | -3.2% | +54.0% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 4,900 | $23.41 | $114,709.00 | -3.1% | +54.0% | - | |
| Oct 10, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 3,658 | $863.24 | $3,157,722.23 | - | +30.2% | - | |
| Oct 10, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 900 | $58.25 | $52,425.00 | -0.3% | -37.2% | - | |
| Oct 10, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $446.81 | $3,574,443.50 | -51.1% | +11.6% | - | |
| Oct 9, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 10,602 | $852.49 | $9,038,055.41 | - | +29.5% | - | |
| Oct 9, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 30,000 | $0.24 | $7,272.00 | -0.6% | - | - | |
| Oct 9, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 59,900 | $50.57 | $3,029,336.39 | -2.4% | +3.5% | - | |
| Oct 9, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Newhall Charles W III | Director | Sell | 25,000 | $50.77 | $1,269,234.00 | -10.6% | +3.5% | - | |
| Oct 8, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 101,420 | $850.27 | $86,234,873.84 | - | +25.8% | - | |
| Oct 8, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $451.35 | $3,610,769.33 | -43.1% | +12.0% | - | |
| Oct 7, 2025 | EBS Emergent Biosolutions Inc. | Glessner Coleen | EVP, Quality &Ethics, And Cpl | Sell | 30,608 | $10.00 | $306,080.00 | -17.5% | +29.5% | - | |
| Oct 7, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 26,795 | $848.01 | $22,722,401.16 | - | +23.5% | - | |
| Oct 6, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 161,183 | $850.22 | $137,041,656.51 | - | +23.2% | - | |
| Oct 6, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael | President And COO | Sell | 22,500 | $450.24 | $10,130,438.91 | -33.6% | +8.0% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.